Welcome to our dedicated page for Exyn Technologies SEC filings (Ticker: EXYN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Exyn Technologies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Exyn Technologies's regulatory disclosures and financial reporting.
Exyn Technologies, Inc. (EXYN) filed a prospectus supplement for the resale by existing selling stockholders of up to 3,658,564 shares of common stock and 189,753 warrants. Exyn will not receive proceeds from these resales. Its common stock and warrants trade on Nasdaq under “EXYN” and “EXYNW,” last closing at $2.02 and $0.66, respectively, on August 19, 2026.
Exyn’s June 30, 2026 balance sheet shows total assets of $11.8 million, including $7.8 million in cash and cash equivalents, and total liabilities of $6.2 million, for positive stockholders’ equity of $5.6 million. For the six months ended June 30, 2026, revenue was $2.1 million with a net loss of $10.1 million. The company completed an IPO on May 18, 2026, raising gross proceeds of approximately $19.4 million, and used a portion to repay prior debt. Exyn discloses recurring losses, negative operating cash flows and states that its current cash is expected to be insufficient for the next 12 months, indicating substantial doubt about its ability to continue as a going concern absent additional financing.
Exyn Technologies, Inc. (EXYN) furnished an update covering second-quarter 2026 results and a major leadership change. The company announced financial results for the quarter ended June 30, 2026, highlighting a strategy focused on expanding software and subscription revenue, scaling its ExynAI autonomy platform, and accelerating growth in defense and national security markets. No detailed financial figures are included here, but management emphasized increasing higher-margin software and subscription contributions and gross margin expansion.
Separately, the board appointed Ben Williams, previously Chief Operating Officer, as Interim Chief Executive Officer, and Gregory McNeal as Chairman of the Board, effective August 19, 2026, following the resignation of Brandon Torres Declet as CEO and Chair. The company also notes risks related to its ability to continue as a going concern, the need to raise substantial additional funds, an Audit Committee internal investigation, and remediation of material weaknesses in internal control over financial reporting, as referenced in its amended Form 10-Q.
Exyn Technologies, Inc. (EXYN) filed an amended quarterly report for the period ended June 30, 2026, mainly to correct narrative disclosures about the resignation of its former CEO and board chair and to identify the Interim CEO as the chief operating decision maker; the underlying financial statements are unchanged.
For the quarter, Exyn generated $949,604 in revenue, down from $1,357,757 a year earlier, and recorded a net loss of $6,893,875 versus $2,921,967 in the prior-year quarter. For the first six months of 2026, revenue was $2,140,201 with a net loss of $10,132,660. Operating expenses rose significantly, driven by higher selling, general and administrative and research and development costs, along with notable non-operating charges related to debt modification and settlement.
Following a May 2026 IPO of 2,500,000 units at $7.75 per unit, cash and cash equivalents increased to $7,835,535 at June 30, 2026 and current liabilities fell to $6,098,724, improving stockholders’ equity from a deficit of $(11,310,726) at December 31, 2025 to positive equity of $5,574,084. However, Exyn discloses substantial doubt about its ability to continue as a going concern over the next 12 months, noting that current cash, including approximately $4,485,103 as of August 19, 2026, is not expected to cover projected operating requirements without additional financing.
Exyn Technologies, Inc. (EXYN) reported continued operating losses for the quarter ended June 30, 2026 and disclosed that its financial statements are prepared under a going concern assumption with substantial doubt about its ability to continue for 12 months. Quarterly revenue fell to $0.95 million from $1.36 million, while the net loss widened to $6.9 million from $2.9 million, driven by higher selling, general and administrative and research and development expenses and sizable non‑operating charges.
For the first six months of 2026, revenue declined to $2.14 million from $2.58 million, with a net loss of $10.1 million. Cash and cash equivalents increased to $7.84 million at June 30, 2026, largely due to a May 2026 IPO of 2,500,000 units at $7.75 per unit, which generated approximately $19.4 million in gross proceeds. The company used a significant portion of the IPO proceeds to repay the Western Alliance Bank term loan and a high‑cost Maximcash loan, and converted SAFEs and several convertible notes into equity, shifting from a shareholders’ deficit of $(11.3) million at December 31, 2025 to positive equity of $5.57 million at June 30, 2026. Management states that current cash of approximately $4.49 million as of August 19, 2026 is not expected to cover projected needs for the next year, and that additional, potentially dilutive financing will be required.
Exyn Technologies, Inc. notified that it will file its Form 10-Q for the quarter ended June 30, 2026 late. The Audit Committee, assisted by outside counsel, is conducting an internal investigation into allegations regarding use of a company credit card by an executive officer, and the company has placed that officer on leave. Because the investigation and related accounting review are ongoing, Exyn could not complete the report by the August 14, 2026 due date, but expects to file within five calendar days. For the three and six months ended June 30, 2026, Exyn expects higher operating expenses and a higher net loss than a year earlier, and lower revenues, driven mainly by public company costs, note-related non-operating expenses, and timing of customer projects and product deliveries.
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh report beneficial ownership of 774,000 shares of Exyn Technologies, Inc. common stock on a Schedule 13G. This represents 9.73% of the outstanding common stock as of June 30, 2026.
The reported position consists of 387,000 common shares and 387,000 shares issuable upon exercise of warrants. All voting and dispositive power over these securities is held on a shared basis, with no sole voting or dispositive power reported for any of the filing persons.
Exyn Technologies, Inc. director Gregory S. McNeal received a grant of stock options covering 23,200 shares of common stock on August 3, 2026. The options have an exercise price of $1.82 per share, expire on 2036-08-03, and vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, contingent on continued service. Following the grant, he holds options on 23,200 shares.
Exyn Technologies, Inc. reported that director and Chief Executive Officer Torres Declet Brandon received a grant of stock options on August 3, 2026 to purchase 109,000 shares of common stock at an exercise price of $1.82 per share. These options expire on August 3, 2036 and vest as follows: 25% of the shares vest on August 3, 2027 and the remaining shares vest in equal monthly installments, subject to Torres Declet Brandon continuing as a service provider through each vesting date. Following this award, the reporting person holds 109,000 stock options directly.
Exyn Technologies, Inc. reported that director Tewksbury Ted L III received a grant of stock options covering 23,200 shares of common stock on August 3, 2026 at an exercise price of $1.82 per share.
The options vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, expire on August 3, 2036, and result in direct holdings of 23,200 stock options.
Exyn Technologies, Inc. director Ollwerther Jonathan Carey received a grant of stock options for 23,200 shares of common stock on August 3, 2026. The options have an exercise price of $1.82 per share, expire on August 3, 2036, and vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to continued service.